3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Carcinoma, Hepatocellular
6
Hepatitis B, Chronic
4
Lymphoma
2
Hepatitis B
2
Virus Diseases
1
Recurrence
1
Paraparesis, Tropical Spastic
1
Neuritis
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia-Lymphoma, Adult T-Cell
1
Infections
1
HTLV-I Infections
1
Fibrosis
1
Epstein-Barr Virus Infections
1
Burkitt Lymphoma
1
Interventions
Lenalidomide
2
Cyclophosphamide
2
peginterferon alfa-2b
1
etoposide phosphate
1
dolutegravir
1
belinostat
1
Zidovudine
1
Vincristine
1
Tenofovir
1
Raltegravir Potassium
1
Prednisone
1
Introns
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Doxorubicin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia-Lymphoma, Adult T-Cell
×
Tenofovir
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled